- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cervical Cancer and HPV Research
- Cancer Risks and Factors
- Economic and Financial Impacts of Cancer
- Multiple and Secondary Primary Cancers
- Global Public Health Policies and Epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Advances in Oncology and Radiotherapy
- Esophageal Cancer Research and Treatment
- Genetic factors in colorectal cancer
- Lung Cancer Treatments and Mutations
- Global Health Care Issues
- Endometrial and Cervical Cancer Treatments
- Acute Lymphoblastic Leukemia research
- Lung Cancer Diagnosis and Treatment
- Childhood Cancer Survivors' Quality of Life
- Ovarian cancer diagnosis and treatment
- Prostate Cancer Diagnosis and Treatment
- Testicular diseases and treatments
- Liver Disease Diagnosis and Treatment
- Nutritional Studies and Diet
- Head and Neck Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Hepatitis B Virus Studies
Centre International de Recherche sur le Cancer
2016-2025
Pennine Acute Hospitals NHS Trust
2024
Cancer Registry of Norway
2005-2023
Université de Lille
2018-2023
Miniaturisation pour la Synthèse, l'Analyse et la Protéomique
2018-2023
Centre National de la Recherche Scientifique
2018-2023
World Health Organization - Pakistan
2021-2022
World Health Organization
2021
UNSW Sydney
2019
The University of Sydney
2019
Abstract This article provides an update on the global cancer burden using GLOBOCAN 2020 estimates of incidence and mortality produced by International Agency for Research Cancer. Worldwide, estimated 19.3 million new cases (18.1 excluding nonmelanoma skin cancer) almost 10.0 deaths (9.9 occurred in 2020. Female breast has surpassed lung as most commonly diagnosed cancer, with 2.3 (11.7%), followed (11.4%), colorectal (10.0 %), prostate (7.3%), stomach (5.6%) cancers. Lung remained leading...
Abstract This article provides a status report on the global burden of cancer worldwide using GLOBOCAN 2018 estimates incidence and mortality produced by International Agency for Research Cancer, with focus geographic variability across 20 world regions. There will be an estimated 18.1 million new cases (17.0 excluding nonmelanoma skin cancer) 9.6 deaths (9.5 in 2018. In both sexes combined, lung is most commonly diagnosed (11.6% total cases) leading cause death (18.4% deaths), closely...
Statistics are given for global patterns of cancer incidence and mortality males females in 23 regions the world.
Estimates of the worldwide incidence and mortality from 27 major cancers for all combined 2012 are now available in GLOBOCAN series International Agency Research on Cancer. We review sources methods used compiling national cancer estimates, briefly describe key results by site 20 large "areas" world. Overall, there were 14.1 million new cases 8.2 deaths 2012. The most commonly diagnosed lung (1.82 million), breast (1.67 colorectal (1.36 million); common causes death (1.6 deaths), liver...
Abstract Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because the growth aging population, as well prevalence established risk factors such smoking, overweight, physical inactivity, changing reproductive patterns associated with urbanization economic development. Based GLOBOCAN estimates, about 14.1 million new cases 8.2 deaths occurred 2012 worldwide. Over years, has shifted to countries,...
Estimates of the worldwide incidence and mortality from 27 cancers in 2008 have been prepared for 182 countries as part GLOBOCAN series published by International Agency Research on Cancer. In this article, we present results 20 world regions, summarizing global patterns eight most common cancers. Overall, an estimated 12.7 million new cancer cases 7.6 deaths occur 2008, with 56% 63% occurring less developed regions world. The commonly diagnosed are lung (1.61 million, 12.7% total), breast...
Estimates of the worldwide incidence, mortality and prevalence 26 cancers in year 2002 are now available GLOBOCAN series International Agency for Research on Cancer. The results presented here summary form, including geographic variation between 20 large "areas" world. Overall, there were 10.9 million new cases, 6.7 deaths, 24.6 persons alive with cancer (within three years diagnosis). most commonly diagnosed lung (1.35 million), breast (1.15 colorectal (1 million); common causes death (1.18...
With increasing incidence and mortality, cancer is the leading cause of death in China a major public health problem. Because China's massive population (1.37 billion), previous national mortality estimates have been limited to small samples using data from 1990s or based on specific year. high‐quality an additional number population‐based registries now available through National Central Cancer Registry China, authors analyzed 72 local, (2009‐2011), representing 6.5% population, estimate...
Estimates of the worldwide incidence and mortality from 36 cancers for all combined year 2018 are now available in GLOBOCAN database, compiled disseminated by International Agency Research on Cancer (IARC). This paper reviews sources methods used compiling cancer statistics 185 countries. The validity national estimates depends upon representativeness source information, to take into account possible bias, uncertainty intervals provided estimated sex- site-specific all-ages number new cases...
Abstract This article presents global cancer statistics by world region for the year 2022 based on updated estimates from International Agency Research Cancer (IARC). There were close to 20 million new cases of in (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 deaths NMSC). The suggest that approximately one five men or women develop a lifetime, whereas around nine and 12 die it. Lung was most frequently diagnosed 2022, responsible almost 2.5 cases, eight worldwide (12.4% all...
IntroductionCancer incidence and mortality estimates for 25 cancers are presented the 40 countries in four United Nations-defined areas of Europe European Union (EU-27) 2012.MethodsWe used statistical models to estimate national rates 2012 from recently-published data, predicting year recent trends, wherever possible. The estimated were applied corresponding population obtain numbers new cancer cases deaths 2012.ResultsThere an 3.45 million (excluding non-melanoma skin cancer) 1.75 2012....
<h3>Objective</h3> The global burden of colorectal cancer (CRC) is expected to increase by 60% more than 2.2 million new cases and 1.1 deaths 2030. In this study, we aim describe the recent CRC incidence mortality patterns trends linking findings prospects reducing through prevention care. <h3>Design</h3> Estimates sex-specific rates in 2012 were extracted from GLOBOCAN database. Temporal assessed for 37 countries using data <i>Cancer Incidence Five Continents</i> (CI5) volumes I–X WHO...
Our study briefly reviews the data sources and methods used in compiling International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics year 2020 summarises main results. National estimates were calculated based best available incidence from population-based registries (PBCR) mortality World Health Organization database. rates by sex age groups estimated 38 sites 185 countries or territories worldwide. There an 19.3 million (95% uncertainty interval [UI]: 19.0-19.6 million)...
Describing the distribution of disease between different populations and over time has been a highly successful way devising hypotheses about causation for quantifying potential preventive activities.1 Statistical data are also essential components surveillance programs. These play critical role in development implementation health policy, through identification problems, decisions on priorities curative programs evaluation outcomes prevention, early detection/screening treatment relation to...
The knowledge that persistent human papillomavirus (HPV) infection is the main cause of cervical cancer has resulted in development prophylactic vaccines to prevent HPV and assays detect nucleic acids virus. WHO launched a Global Initiative scale up preventive, screening, treatment interventions eliminate as public health problem during 21st century. Therefore, our study aimed assess existing burden baseline from which effect this initiative.
Recent estimates of global cancer incidence and survival were used to update previous figures limited duration prevalence the year 2008. The number patients with diagnosed between 2004 2008 who still alive at end in adult population is described by world region, country human development index. 5-year estimated be 28.8 million Close half burden areas very high that comprise only one-sixth world's population. Breast continues most prevalent vast majority countries globally; cervix much...
BackgroundInfectious pathogens are strong and modifiable causes of cancer. The aim this study was to improve estimates the global regional burden infection-attributable cancers inform research priorities facilitate prevention efforts.MethodsWe used GLOBOCAN 2018 database cancer incidence mortality rates estimated attributable fractions for specific anatomical sites, subsites, or histological subtypes known be associated with ten infectious classified as human carcinogens. We calculated...
The relative importance of cardiovascular disease (CVD) and cancer as leading causes premature death are examined in this communication. CVD now the 127 countries, with 70 countries (including Brazil India) 57 China). Such observations can be seen part a late phase an epidemiologic transition, taking place second half 20th century first present one, which dominance infectious diseases is progressively superseded by noncommunicable diseases. According to ranks recent trends, may surpass cause...
We present here worldwide estimates of annual mortality from all cancers and for 25 specific cancer sites around 1990. Crude age-standardised rates numbers deaths were computed 23 geographical areas. Of the estimated 5.2 million (excluding non-melanoma skin cancer), 55% (2.8 million) occurred in developing countries. The sex ratio is 1.33 (M:F), greater than that incidence (1.13) due to more favourable prognosis women. Lung still most common cause death with over 900,000 per year, followed...